A healthcare professional measures a woman's blood pressure using a sphygmomanometer, with the woman seated and wearing a denim jacket.

Medical Weight Loss (GLP-1) Therapy

GLP-1 Medical Weight Loss Program

Our GLP-1 Medical Weight Loss Program offers a comprehensive, medically supervised approach to sustainable weight management. GLP-1 medications work by helping regulate appetite, improve satiety, and support healthy blood sugar balance—making it easier to achieve meaningful, long-term weight loss when combined with lifestyle changes.

All GLP-1 treatments are provided under medical oversight and require an initial consultation and ongoing follow-up to ensure safety, effectiveness, and individualized care.


How GLP-1 Therapy Works

GLP-1 (Glucagon-Like Peptide-1) medications mimic a naturally occurring hormone in the body that helps regulate appetite and digestion. By slowing gastric emptying and promoting a feeling of fullness, GLP-1 therapy can help reduce cravings, portion sizes, and overeating.

This therapy is designed to support sustainable lifestyle changes rather than quick fixes and is most effective when paired with nutrition, movement, and behavioral support.


GLP-1 Medication Options: Semaglutide vs. Tirzepatide

Both semaglutide and tirzepatide are prescription GLP-1–based medications used to support medical weight loss. While they work in similar ways, there are key differences that may influence which option is best for you.

Semaglutide

Semaglutide works by mimicking the GLP-1 hormone, which helps regulate appetite, slow digestion, and promote feelings of fullness.

Commonly chosen for:
• Appetite and craving control
• Gradual, steady weight loss
• Individuals new to GLP-1 therapy
• Those seeking a lower-dose starting option

Tirzepatide

Tirzepatide acts on two hormone pathways (GLP-1 and GIP), which may provide enhanced appetite suppression and metabolic support for some individuals.

Commonly chosen for:
• Individuals needing stronger appetite support
• Those who have not responded optimally to other therapies
• Clients seeking enhanced metabolic support

Potential Benefits May Include

• Reduced appetite and cravings
• Improved portion control and satiety
• Support for gradual, sustainable weight loss
• Improved metabolic health
• Increased energy and confidence over time

Individual results may vary. GLP-1 therapy is not intended to diagnose, treat, cure, or prevent disease.


Who It’s Best For

GLP-1 therapy may be a good option for individuals who:

• Have struggled with weight loss despite diet and exercise
• Experience frequent hunger or cravings
• Want a medically guided approach to weight management
• Are seeking long-term, sustainable results
• Are committed to lifestyle and behavior changes alongside treatment

All clients must complete a medical intake and provider consultation to determine eligibility.


What’s Included in the Program

• Initial medical consultation and health screening
• Provider-guided treatment plan
• Prescription GLP-1 medication (as appropriate)
• Ongoing monitoring and dose adjustments
• Education and support throughout treatment
• Required follow-up visits every 90 days


GLP-1 Medical Weight Loss Pricing

Medication type and dosing are determined by your medical provider based on individual goals, response, and clinical appropriateness.

Tirzepatide
(Monthly Pricing)

• 2.0 mg — $195 / month
• 3.5 mg — $280 / month
• 6.0 mg — $310 / month
• 8.5 mg — $345 / month
• 11 mg — $380 / month
• 13.5 mg — $435 / month

Semaglutide
(Monthly Pricing)

• 0.22 mg — $140 / month
• 0.45 mg — $160 / month
• 0.9 mg — $185 / month
• 1.5 mg — $200 / month
• 2.16 mg — $250 / month

Monthly medication pricing includes:

• Prescription medication
• Ongoing provider oversight
• Program support and education

Additional Program Fees: Initial medical consultation (one-time): $60 | Follow-up telehealth visit: $40 every 90 days



GLP-1 medications are prescription-only and may not be appropriate for everyone. Treatment eligibility is determined through a medical intake and provider consultation.

GLP-1 therapy is not recommended for individuals who are pregnant or breastfeeding, have a personal or family history of certain thyroid cancers, or have specific medical conditions. All risks, benefits, and expectations will be reviewed prior to starting treatment.

Safety & Medical Oversight


Ready to get started?

Medical weight loss begins with an initial consultation to determine if GLP-1 therapy is right for you. Book an initial consultation to discuss your goals, medical history, and personalized treatment options.

Book Now
Policies

GLP-1 Medical Weight Loss: Frequently Asked Questions

  • Many clients notice reduced appetite and improved portion control within the first few weeks. Weight loss varies by individual and is influenced by dose, consistency, and lifestyle habits.

  • There is no required diet plan; however, GLP-1 therapy works best when paired with balanced nutrition, adequate protein intake, hydration, and regular movement. Guidance is provided during your program.

  • Some clients experience nausea, constipation, diarrhea, or fatigue—especially during dose adjustments. These effects are often temporary and improve as your body adapts. Your provider will monitor tolerance closely.

  • Length of treatment varies. Some clients use GLP-1 therapy short-term to jump-start weight loss, while others choose longer-term support. This is discussed and adjusted based on your goals and response.

  • GLP-1 medications are FDA-approved and widely used when prescribed appropriately. All clients complete a medical intake and are monitored regularly to ensure safety and effectiveness.

  • Yes. Many clients choose to add injections such as B12 or Lipo-Mino to support energy, metabolism, and nutrient balance while on GLP-1 therapy.

  • Stopping GLP-1 therapy may result in increased appetite if lifestyle habits are not maintained. We focus on building sustainable habits throughout your program to support long-term success.

  • No. GLP-1 therapy is not appropriate for individuals who are pregnant or breastfeeding, have certain medical conditions, or specific family histories. Eligibility is determined during consultation.